PENK and neurodegenerative disease: In the present study, we investigated, for the first time, the levels of the PDYN- and PENK-derived peptides in patients with sCJD to thereby provide new insights into the possible mechanisms underlying the dysregulation of brain opioids in neurodegenerative diseases.